Most Recent
A class action against Sydney doctor Daniel Lanzer and several of his associates over alleged botched cosmetic surgeries wants to drop its claims against one doctor, but other defendants have taken issue.
US drug maker Allergan may defend a class action over recalled textured breast implants by arguing its knowledge of the alleged defects was limited by the state of scientific knowledge at the time the products were made.
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
Construction PRO
Real estate fund manager Charter Hall has paid $47 million to purchase a Clinipath Pathology lab in Perth, bolstering its social infrastructure investment trust.
A nurses union has won orders barring St Vincent's Private from representing to nurses that protected industrial action in relation to the closure of beds at various hospitals is unlawful and unprotected.
Legal fees will eat up more than half of a $3.5 million settlement reached in a class action over deaths at a NSW aged care facility during the COVID-19 pandemic.
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Global law firm K&L Gates has hired former Corrs Chambers Westgarth IP litigator Rachelle Downie as a partner in its Melbourne office.
Law firm Gordon Legal has filed a tenth class action on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after several landmark wins in similar cases.
A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.